Which cyclosporin formulation? [24]

Lancet

Volumn 348, Issue 9021, 1996, Pages 205-

  Bennett, W M ^a   Demattos, A ^a   Norman, D J ^a   Meyer, M M ^a   Olyaei, A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; CYCLOSPORIN;

ADULT; CASE REPORT; DRUG FORMULATION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; BIOAVAILABILITY; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PHARMACOKINETICS;

BIOLOGICAL AVAILABILITY; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; THERAPEUTIC EQUIVALENCY;

EID: 0030594793     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66159-4     Document Type: Letter

References (0)